Matão Controlling Hypertension (MatCH) project: Rationale and design
| Autor: | Arthur Augusto Ribeiro Ferreira, Geraldo Cássio dos Reis, Antônio Durval Martins Peres, Flavio Antonio Borsetti Neto, Lucileni Aparecida Borin, Denise Paolinetti Camara Minelli, Liliana Tiene Ujikawa, Paulo Cicogna Neto, Ariany de Souza Leite, Norberto L. Cabral, João Luiz Carmo, Maria Silvia Vichi, Cesar Minelli, Fumiu Iwachima, Esther Maria Langhi Chiozzini |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Pediatrics Population Developing country Pharmacy 030204 cardiovascular system & hematology Asymptomatic Article 03 medical and health sciences 0302 clinical medicine medicine 030212 general & internal medicine Risk factor education Blood-pressure control Pharmacology lcsh:R5-920 education.field_of_study Population community-based study business.industry General Medicine Awareness Blood pressure Family medicine Community health Hypertension Population study medicine.symptom lcsh:Medicine (General) business |
| Zdroj: | Contemporary Clinical Trials Communications Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 234-240 (2017) |
| ISSN: | 2451-8654 |
| Popis: | Background Hypertension is the main risk factor for most cardiovascular diseases. A coordinated and organized system from the Brazilian Ministry of Healthy involving Family Health Strategy (FHS), a program for the prevention of chronic disease, and the Popular Pharmacy Program (PPP), which subsidizes medications for the population, could allow an earlier identification and better blood pressure (BP) control. Matao Controlling Hypertension (MatCH) is a community-based population project that aims to apply an organized, integrated and coordinated program in the city of Matao, Brazil, involving FHS and PPP in order to actively search, treat and follow-up hypertensive subjects. Method This is a population community-based, interventional, follow-up study where all subjects aged ≥ 40 years assisted by the FHS program in Matao will have BP assessed monthly by trained Community Health Agents (CHA) during a domiciliary visit. Identified hypertensive subjects will be referred to FHS physicians for nonpharmacological and pharmacological treatment. Most of the hypertensive drugs used will be available through the PPP. Prevalence of hypertension, awareness, demographics and risk factors will be correlated with BP control. The population study is expected to involve approximately 18.600 subjects. The study period will be four years. Discussion Considering that hypertension is asymptomatic in most cases, to reduce the population burden of BP-related deaths and diseases it is essential to detect and treat early all hypertensive patients. If we achieve our large-scale BP control, this program can be applied to other populations from developing countries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|